Julián R Reguero Selected Research

Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)

1/2018	Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy.
10/2014	Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy.
9/2013	Profile of microRNAs in the plasma of hypertrophic cardiomyopathy patients compared to healthy controls.
9/2012	Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.
11/2011	Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations.
7/2010	Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier.
2/2009	Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
9/2006	Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy.
7/2005	Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect.
10/2003	[Direct detection of malignant mutations in patients with hypertrophic cardiomyopathy].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julián R Reguero Research Topics

Disease

11	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018 - 08/2003
6	Myocardial Infarction 01/2011 - 08/2002
4	Atherosclerosis 01/2019 - 03/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 07/2002
4	Cardiomegaly (Heart Hypertrophy) 01/2018 - 09/2007
2	Hypertension (High Blood Pressure) 06/2018 - 08/2009
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2010 - 02/2009
1	Inflammation (Inflammations) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 06/2018
1	Heart Failure 01/2018
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 10/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2010
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2008
1	Cardiomyopathies (Cardiomyopathy) 10/2003
1	Sudden Death 10/2003
1	Hyperplasia 03/2003
1	Atherosclerotic Plaque (Atheroma) 08/2002

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 08/2002
3	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2011
3	Mitochondrial DNA (mtDNA)IBA 01/2011 - 09/2006
3	Troponin T (Troponin T1)IBA 09/2007 - 08/2003
2	NF-kappa B (NF-kB)IBA 01/2019 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 08/2002
2	Serotonin (5 Hydroxytryptamine)IBA 07/2010 - 03/2003
2	Ventricular MyosinsIBA 10/2003 - 08/2003
1	CholesterolIBA 06/2018
1	Long Noncoding RNAIBA 01/2018
1	FilaminsIBA 10/2014
1	3' Untranslated Regions (3' UTR)IBA 09/2012
1	Oxygen (Dioxygen)IBA 01/2011
1	AngiotensinsIBA 07/2010
1	Matrix Metalloproteinases (MMPs)IBA 09/2009
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2009
1	Endothelin-1 (Endothelin 1)IBA 08/2009
1	MEF2 Transcription FactorsIBA 02/2009
1	Transcription Factors (Transcription Factor)IBA 01/2008
1	A-Form DNA (A-DNA)IBA 03/2007
1	Cardiac MyosinsIBA 07/2005
1	Carrier Proteins (Binding Protein)IBA 07/2005
1	myosin-binding protein CIBA 07/2005
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2003
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2003
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 08/2002
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 08/2002
1	LipidsIBA 08/2002
1	Lipoprotein(a)IBA 07/2002